Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by rjc7on Nov 09, 2020 12:50pm

81 Views

Post# 31863609

RE:RE:House #143 Pershing Securities

i'd like to think it was a shorter covering except "Ochung", a poster on this board posted the short position on Friday as being only 25,300 shares. Who knows why they sold but it was also the manner in which they sold......never sat on the ask side. Just sold into the bid regardless of the price.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal